Advertisement
U.S. markets closed
S&P Futures
5,747.50 +4.25 (+0.07%) Dow Futures
41,983.00 +27.00 (+0.06%) Nasdaq Futures
20,100.50 +14.50 (+0.07%) Russell 2000 Futures
2,230.70 -0.40 (-0.02%) Crude Oil
71.53 +0.06 (+0.08%) Gold
2,738.30 -7.90 (-0.29%)
Aquestive Therapeutics, Inc. (AQST)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 5.52 |
| Open | 5.50 |
| Bid | 5.10 x 100 |
| Ask | 5.19 x 100 |
| Day's Range | 5.12 - 5.52 |
| 52 Week Range | 1.55 - 6.23 |
| Volume | |
| Avg. Volume | 1,264,422 |
| Market Cap | 502.65M |
| Beta (5Y Monthly) | 2.84 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Aquestive Therapeutics (AQST) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- Zacks
Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -8.33% and 6.68%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.